Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 2 EP applications Johanna Elise Wilkinson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11774271

COMPOUNDS AS AGONISTS OF S1P1 RECEPTORS

IPC classification:
A61K 31/422, A61K 31/4245, A61K 31/427, A61K 31/433, A61K 31/4439, A61K 31/55, A61P 3/10, A61P 9/00, A61P 11/06, A61P 31/00, A61P 31/12, A61P 35/04, A61P 37/00, A61P 43/00, C07D 413/10, C07D 413/14, C07D 417/10, C07D 417/14
Applicant:
Glaxo Group Limited
Agent:
Johanna Elise Wilkinson, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15813099

POWDER FORMULATION

IPC classification:
A61K 9/14, A61K 38/11
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Johanna Elise Wilkinson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature